Ehab Atallah
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 138
- Chronic Myeloid Leukemia Treatments 80
- Acute Myeloid Leukemia Research 68
- Hematopoietic Stem Cell Transplantation 14
- Genetics 71
- Chronic Lymphocytic Leukemia Research 49
- Myeloproliferative Neoplasms: Diagnosis and Treatment 24
- Co-authors
- Jörge E. CortesLawrence E. FlahertyHagop KantarjianJean‐Bernard DurandCharles A. SchifferHagop M. KantarjianGuru Subramanian Guru MurthySrđan Verstovšek
- Journals
- Blood (64 papers)Journal of Clinical Oncology (16 papers)Leukemia Research (6 papers)Current Hematologic Malignancy Reports (6 papers)Cancer (3 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Ehab Atallah
167 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 89
- Hematology 1.2k
- Genetics 649
- Oncology 564
- Rheumatology 277
- Public Health, Environmental and Occupational Health 332
Countries citing papers authored by Ehab Atallah
This map shows the geographic impact of Ehab Atallah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehab Atallah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehab Atallah more than expected).
Fields of papers citing papers by Ehab Atallah
This network shows the impact of papers produced by Ehab Atallah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehab Atallah. The network helps show where Ehab Atallah may publish in the future.
Co-authors
The 25 scholars most cited alongside Ehab Atallah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 12 | |
| 7 | 2023 | 29 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 5 | |
| 13 | 2018 | 10 | |
| 14 | 2017 | 10 | |
| 15 | 2017 | 8 | |
| 16 | Treatment Patterns in Patients with Chronic Myeloid Leukemia in Chronic Phase in US Clinical Practice, with a Focus on Tyrosine Kinase Inhibitor Therapy Discontinuation | 2017 | 1 |
| 17 | 2017 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2014 | 5 | |
| 20 | 2012 | 6 |
About Ehab Atallah
Ehab Atallah is a scholar working on Hematology, Genetics, Rheumatology, Oncology and Public Health, Environmental and Occupational Health, having authored 175 papers that have together received 2.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (80 papers), Acute Myeloid Leukemia Research (68 papers), Chronic Lymphocytic Leukemia Research (49 papers), Acute Lymphoblastic Leukemia research (34 papers), Eosinophilic Disorders and Syndromes (29 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers), Histone Deacetylase Inhibitors Research (22 papers) and Hematopoietic Stem Cell Transplantation (14 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (649 citations), Oncology (564 citations), Rheumatology (277 citations) and Public Health, Environmental and Occupational Health (332 citations). Ehab Atallah has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Jörge E. Cortes, Lawrence E. Flaherty, Hagop Kantarjian, Jean‐Bernard Durand, Charles A. Schiffer, Hagop M. Kantarjian, Guru Subramanian Guru Murthy, Srđan Verstovšek, Guillermo Garcia‐Manero and Kathryn E. Flynn. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Current Hematologic Malignancy Reports and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.